Search tips
Search criteria 


Logo of brjopthalBritish Journal of OphthalmologyCurrent TOCInstructions for authors
Br J Ophthalmol. 2007; 91(12): 1607–1609.
Published online May 23, 2007. doi:  10.1136/bjo.2007.119495
PMCID: PMC2095545
Early onset vitreous amyloidosis in familial amyloidotic polyneuropathy with a transthyretin Glu54Gly mutation is associated with elevated vitreous VEGF
Thomas M O'Hearn, Amani Fawzi, Shikun He, Narsing A Rao, and Jennifer I Lim
T M O'Hearn, A Fawzi, S He, N A Rao, J I Lim, Doheny Eye Institute, Keck School of Medicine, University of Southern California, California, USA
Correspondence to: Dr Jennifer I Lim
Retina Service, Eye and Ear Infirmary, University of Illinois, 1855W Taylor St, Suite 2.50, Chicago, IL 60612, USA;
Accepted May 3, 2007.
To report the early vitreous involvement in a rare familial amyloidotic polyneuropathy (FAP) mutation and associated vitreous vascular endothelial growth factor (VEGF) levels.
Observational case series.
Review of clinical, pathological, photographic,
and angiographic records of two FAP siblings with severe vitreous involvement. Laboratory ELISA analysis of vitreous samples for VEGF, and DNA sequence analysis of peripheral blood for transthyretin (TTR) mutational analysis.
Two patients underwent 25‐gauge vitrectomy in three eyes with marked improvement of visual acuity. Neovascularisation seen intraoperatively responded to endolaser. Analysis of vitrectomy samples for VEGF showed raised levels in all three specimens. Mutational analysis revealed an isolated Glu54Gly mutation in the transthyretin gene.
Early involvement of the vitreous occurs in a rare transthyretin mutation of FAP, with increased vitreous levels of VEGF.
Keywords: retina, amyloid, VEGF
Articles from The British Journal of Ophthalmology are provided here courtesy of
BMJ Group